Interactions between grapefruit juice and psychotropic medications: an update of the literature and an original case series

References

• Santos CA, Boullata JI. An approach to evaluating drug-nutrient interactions. Pharmacotherapy. 2005;25:1789–1800. doi: 10.1592/phco.2005.25.12.1789
   PubMed Web of Science ®Google Scholar
• Thomas M, Boggs AA, DiPaula B, et al. Adverse drug reactions in hospitalized psychiatric patients. Ann Pharmacother. 2010;44(5):819–825. doi: 10.1345/aph.1M746
   PubMed Web of Science ®Google Scholar
• Siwek M, Woroń J, Wrzosek A, et al. Harder, better, faster, stronger? Retrospective chart review of adverse events of interactions between adaptogens and antidepressant drugs. Front Pharmacol. 2023;14:1271776. doi: 10.3389/fphar.2023.1271776
   PubMed Web of Science ®Google Scholar
• Woroń J, Siwek M. Unwanted effects of psychotropic drug interactions with medicinal products and diet supplements containing plant extracts. Psychiatr Pol. 2018;52(6):983–996. English, Polish. doi: 10.12740/PP/OnlineFirst/80998
   PubMed Web of Science ®Google Scholar
• Wasik A, Krupa A, Siwek M. Interactions of antidepressants, mood-stabilisers and antipsychotics with food. Farmakoter Psychiatr Neurol. 2019;35(1):51–74. doi: 10.33450/fpn.2019.04.002
   Google Scholar
• Kamal M, Negm WA, Abdelkader AM, et al. Most common over-the-counter medications and effects on patients. Eur Rev Med Pharmacol Sci. 2023;27:1654–1666. doi: 10.26355/eurrev_202302_31409
   PubMed Web of Science ®Google Scholar
• Barrenberg E, Garbe E. Use of over-the-counter (OTC) drugs and perceptions of OTC drug safety among German adults. Eur J Clin Pharmacol. 2015;71(11):1389–1396. doi: 10.1007/s00228-015-1929-5
   PubMed Web of Science ®Google Scholar
• Kompoliti K, Fan W, Leurgans S. Complementary and alternative medicine use in Gilles de la Tourette syndrome. Mov Disord. 2009;24(13):2015–2019. doi: 10.1002/mds.22724
   PubMed Web of Science ®Google Scholar
• Moore TJ, Mattison DR. Adult utilization of psychiatric drugs and differences by sex, age, and race JAMA Intern Med. 2017;177(2):274–275. doi: 10.1001/jamainternmed.2016.7507
   Google Scholar
• Santomauro DF, Mantilla Herrera AM, Shadid J, et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet Psychiatry. 2022;9(2):137–150. doi: 10.1016/S2215-0366(21)00395-3
   PubMedGoogle Scholar
• Möller HJ, Seemüller F, Schennach-Wolff R, et al. History, background, concepts and current use of comedication and polypharmacy in psychiatry. Int J Neuropsychopharmacol. 2014;17(7):983–986. doi: 10.1017/S1461145713000837
   PubMed Web of Science ®Google Scholar
• Monteith S, Glenn T. A comparison of potential psychiatric drug interactions from six drug interaction database programs. Psychiatry Res. 2019;275:366–372. doi: 10.1016/j.psychres.2019.03.041
   PubMed Web of Science ®Google Scholar
• Hefner G, Wolff J, Hahn M, et al. Prevalence and sort of pharmacokinetic drug–drug interactions in hospitalized psychiatric patients. J Neural Transm (Vienna). 2020;127:1185–1198. doi: 10.1007/s00702-020-02214-x
   PubMed Web of Science ®Google Scholar
• Briguglio M, Hrelia S, Malaguti M, et al. Food bioactive compounds and their interference in drug pharmacokinetic/pharmacodynamic profiles. Pharmaceutics. 2018;10:1–22. doi: 10.3390/pharmaceutics10040277
   Web of Science ®Google Scholar
• Seden K, Dickinson L, Khoo S, et al. Grapefruit-Drug Interactions. Drugs. 2010;70:2373–2407. doi: 10.2165/11585250-000000000-00000
   PubMed Web of Science ®Google Scholar
• Tassaneeyakul W, Guo LQ, Fukuda K, et al. Inhibition selectivity of grapefruit juice components on human cytochromes P450. Arch Biochem Biophys. 2000;378(2):356–363. doi: 10.1006/abbi.2000.1835
   PubMed Web of Science ®Google Scholar
• Guo LQ, Taniguchi M, Xiao YQ, et al. Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity. Jpn J Pharmacol. 2000;82(2):122–129. doi: 10.1254/jjp.82.122
   PubMedGoogle Scholar
• Igual M, García-Martínez E, Camacho MM, et al. Changes in flavonoid content of grapefruit juice caused by thermal treatment and storage. Innovative Food Sci Emerg Technol. 2011;12(2):153–162. doi: 10.1016/j.ifset.2010.12.010
   Web of Science ®Google Scholar
• De Castro WV, Mertens-Talcott S, Rubner A, et al. Variation of flavonoids and furanocoumarins in grapefruit juices: A potential source of variability in grapefruit juice-drug interaction studies. J Agric Food Chem. 2006;54(1):249–255. doi: 10.1021/jf0516944
   PubMed Web of Science ®Google Scholar
• Ross SA, Ziska DS, Zhao K, et al. Variance of common flavonoids by brand of grapefruit juice. Fitoterapia. 2000;71(2):154–161. doi: 10.1016/s0367-326x(99)00131-8
   PubMed Web of Science ®Google Scholar
• Hanley MJ, Cancalon P, Widmer WW, et al. The effect of grapefruit juice on drug disposition. Expert Opin Drug Metab Toxicol. 2011;7(3):267–286. doi: 10.1517/17425255.2011.553189
   PubMed Web of Science ®Google Scholar
• Ershad M, Cruz MD, Mostafa A, et al. Opioid toxidrome following grapefruit juice consumption in the setting of methadone maintenance. J Addict Med. 2020;14:172–174. doi: 10.1097/ADM.0000000000000535
   PubMed Web of Science ®Google Scholar
• Bailey DG, Dresser GK, Bend JR. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3a4 activity: comparison with grapefruit juice. Clin Pharmacol Ther. 2003;73(6):529–537. doi: 10.1016/S0009-9236(03)00051-1
   PubMed Web of Science ®Google Scholar
• Kupferschmidt HHT, Ha HR, Ziegler WH, et al. Interaction between grapefruit juice and midazolam in humans. Clin Pharmacol Ther. 1995;58:20–28. doi: 10.1016/0009-9236(95)90068-3
   PubMed Web of Science ®Google Scholar
• Veronese ML, Gillen LP, Burke JP, et al. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice. J Clin Pharmacol. 2003;43(8):831–839. doi: 10.1177/0091270003256059
   PubMed Web of Science ®Google Scholar
• Guttman Y, Yedidia I, Nudel A, et al. New grapefruit cultivars exhibit low cytochrome P4503A4-inhibition activity. Food Chem Toxicol. 2020;137:111135. doi: 10.1016/j.fct.2020.111135
   PubMed Web of Science ®Google Scholar
• Ozdemir M, Aktan Y, Boydagm B, et al. Interaction between grapefruit juice and diazepam in humans. Eur J Drug Metab Pharmacokinet. 1998;23(1):55–59. doi: 10.1007/BF03189827
   PubMed Web of Science ®Google Scholar
• Lilja JJ, Kivistö KT, Backman JT, et al. Effect of grapefruit juice dose on grapefruit juice-triazolam interaction: repeated consumption prolongs triazolam half-life. Eur J Clin Pharmacol. 2000;56:411–415. doi: 10.1007/s002280000156
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Von Moltke LL, Harmatz JS, et al. Time course of recovery of cytochrome P450 3A function after single doses of grapefruit juice. Clin Pharmacol Ther. 2003;74(2):121–129. doi: 10.1016/S0009-9236(03)00118-8
   PubMed Web of Science ®Google Scholar
• Cinderella MA, Morell B, Munjal S. Grapefruit juice cleanse mimicking quetiapine overdose: case report and review of literature. J Clin Psychopharmacol. 2021;41(6):690–692. doi: 10.1097/JCP.0000000000001469
   PubMed Web of Science ®Google Scholar
• Thakkar D, Sahu AK, Rathod R, et al. Investigation of the impact of grapefruit juice, pomegranate juice and tomato juice on pharmacokinetics of brexpiprazole in rats using UHPLC–QTOF–MS. Biomed Chromatogr. 2021;35(11):e5201. doi: 10.1002/bmc.5201
   PubMed Web of Science ®Google Scholar
• Paine MF, Criss AB, Watkins PB. Two major grapefruit juice components differ in intestinal CYP3A4 inhibition kinetic and binding properties. Drug Metab Dispos. 2004;32(10):1146–1153. doi: 10.1124/dmd.104.000547
   PubMed Web of Science ®Google Scholar
• Fuhr U, Klittich K, Staib A. Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol. 1993;35(4):431–436. doi: 10.1111/j.1365-2125.1993.tb04162.x
   PubMed Web of Science ®Google Scholar
• He K, Iyer K, Hayes R, et al. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem Res Toxicol. 1998;11(4):252–259. doi: 10.1021/tx970192k
   PubMed Web of Science ®Google Scholar
• Lin HL, Kent UM, Hollenberg PF. The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5. J Pharmacol Exp Ther. 2005;313(1):154–164. doi: 10.1124/jpet.104.079608
   PubMed Web of Science ®Google Scholar
• Yasui N, Kondo T, Suzuki A, et al. Lack of significant pharmacokinetic interaction between haloperidol and grapefruit juice. Int Clin Psychopharmacol. 1999;14(2):113–118. doi: 10.1097/00004850-199903000-00008
   PubMed Web of Science ®Google Scholar
• Akiyoshi T, Uchiyama M, Inada R, et al. Analysis of inhibition kinetics of three beverage ingredients, bergamottin, dihydroxybergamottin and resveratrol, on CYP2C9 activity. Drug Metab Pharmacokinet. 2022;42:100429. doi: 10.1016/j.dmpk.2021.100429
   PubMed Web of Science ®Google Scholar
• Sugimoto KI, Araki N, Ohmori M, et al. Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam. Eur J Clin Pharmacol. 2006;62(3):209–215. doi: 10.1007/s00228-005-0071-1
   PubMed Web of Science ®Google Scholar
• Lee A, Chan W, Harralson A, et al. The effects of grapefruit juice on sertraline metabolism: an in vitro and in vivo study. Clin Ther. 1999;21(11):1890–1899. doi: 10.1016/S0149-2918(00)86737-5
   PubMed Web of Science ®Google Scholar
• Ueda N, Yoshimura R, Umene-Nakano W, et al. Grapefruit juice alters plasma sertraline levels after single ingestion of sertraline in healthy volunteers. World J Biol Psychiatry. 2009;10(4 Pt 3):832–835. doi: 10.1080/15622970802688069
   PubMed Web of Science ®Google Scholar
• Liu D, Wu J, Xie H, et al. Inhibitory effect of hesperetin and naringenin on human UDP-glucuronosyltransferase enzymes: implications for herb-drug interactions. Biol Pharm Bull. 2016;39(12):2052–2059. doi: 10.1248/bpb.b16-00581
   PubMed Web of Science ®Google Scholar
• Bailey DG, Dresser GK, Leake BF, et al. Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clin Pharmacol Ther. 2007;81(4):495–502. doi: 10.1038/sj.clpt.6100104
   PubMed Web of Science ®Google Scholar
• Glaeser H, Bailey DG, Dresser GK, et al. Intestinal drug transporter expression and the impact of grapefruit juice in humans. Clin Pharmacol Ther. 2007;81(3):362–370. doi: 10.1038/sj.clpt.6100056
   PubMed Web of Science ®Google Scholar
• Dresser GK, Bailey DG, Leake BF, et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther. 2002;71(1):11–20. doi: 10.1067/mcp.2002.121152
   PubMed Web of Science ®Google Scholar
• Satoh H, Yamashita F, Tsujimoto M, et al. Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos. 2005;33(4):518–523. doi: 10.1124/dmd.104.002337
   PubMed Web of Science ®Google Scholar
• Ohnishi A, Matsuo H, Yamada S, et al. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by caco-2 cells and on the activity of cytochrome P450 3A4. Br J Pharmacol. 2000;130(6):1369–1377. doi: 10.1038/sj.bjp.0703433
   PubMed Web of Science ®Google Scholar
• Honda Y, Ushigome F, Koyabu N, et al. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. Br J Pharmacol. 2004;143(7):856–864. doi: 10.1038/sj.bjp.0706008
   PubMed Web of Science ®Google Scholar
• Takanaga H, Ohnishi A, Matsuo H, et al. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells. Biol Pharm Bull. 1998;21(10):1062–1066. doi: 10.1248/bpb.21.1062
   PubMed Web of Science ®Google Scholar
• Soldner A, Christians U, Susanto M, et al. Grapefruit juice activates P-Glycoprotein-mediated drug transport. Pharm Res. 1999;16(4):478–485. doi: 10.1023/a:1011902625609
   PubMed Web of Science ®Google Scholar
• DeCastro WV, Mertens-Talcott S, Derendorf H, et al. Grapefruit juice–drug interactions: grapefruit juice and its components inhibit P-Glycoprotein (ABCB1) Mediated Transport of Talinolol in caco-2 cells. J Pharm Sci. 2007;96(10):2808–2817. doi: 10.1002/jps.20975
   PubMed Web of Science ®Google Scholar
• Tian R, Koyabu N, Takanaga H, et al. Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates. Pharm Res. 2002;19(6):802–809. doi: 10.1023/a:1016100715125
   PubMed Web of Science ®Google Scholar
• Eagling VA, Profit L, Back DJ. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-I protease inhibitor saquinavir by grapefruit juice components. Brit J Clinical Pharma. 1999;48(4):543–552. doi: 10.1046/j.1365-2125.1999.00052.x
   PubMed Web of Science ®Google Scholar
• Romiti N, Tramonti G, Donati A, et al. Effects of grapefruit juice on the multidrug transporter P-glycoprotein in the human proximal tubular cell line HK-2. Life Sci. 2004;76(3):293–302. doi: 10.1016/j.lfs.2004.06.015
   PubMed Web of Science ®Google Scholar
• Panchagnula R, Bansal T, Varma MVS, et al. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux. Pharmazie. 2005;60:922–927.
   PubMed Web of Science ®Google Scholar
• Spahn-Langguth H, Langguth P. Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol. Eur J Pharm Sci. 2001;12(4):361–367. doi: 10.1016/s0928-0987(00)00191-3
   PubMed Web of Science ®Google Scholar
• Ahmed IS, Hassan MA, Kondo T. Effect of lyophilized grapefruit juice on P-glycoprotein-mediated drug transport in-vitro and in-vivo. Drug Dev Ind Pharm. 2015;41(3):375–381. doi: 10.3109/03639045.2013.866141
   PubMed Web of Science ®Google Scholar
• Zaidenstein R, Soback S, Gips M, et al. Effect of grapefruit juice on the pharmacokinetics of losartan and its active metabolite E3174 in healthy volunteers. Ther Drug Monit. 2001;23(4):369–373. doi: 10.1097/00007691-200108000-00008
   PubMed Web of Science ®Google Scholar
• Garg SK, Kumar N, Bhargava VK, et al. Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy. Clin Pharmacol Ther. 1998;64(3):286–288. doi: 10.1016/S0009-9236(98)90177-1
   PubMed Web of Science ®Google Scholar
• Hori H, Yoshimura R, Ueda N, et al. Grapefruit juice-fluvoxamine interaction. J Clin Psychopharmacol. 2003;23(4):422–424. doi: 10.1097/01.jcp.0000085423.74359.f2
   PubMed Web of Science ®Google Scholar
• Edwards DJ, Fitzsimmons ME, Schuetz EG, et al. 6’,7’-dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther. 1999;65(3):237–244. doi: 10.1016/S0009-9236(99)70102-5
   PubMed Web of Science ®Google Scholar
• Di Marco MP, Edwards DJ, Wainer IW, et al. The effect of grapefruit juice and Seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein. Life Sci. 2002;71(10):1149–1160. doi: 10.1016/s0024-3205(02)01799-x
   PubMed Web of Science ®Google Scholar
• Shirasaka Y, Suzuki K, Nakanishi T, et al. Differential effect of grapefruit juice on intestinal absorption of statins due to inhibition of organic anion transporting polypeptide and/or P-glycoprotein. J Pharm Sci. 2011;100(9):3843–3853. doi: 10.1002/jps.22586
   PubMed Web of Science ®Google Scholar
• Holmberg MT, Tornio A, Joutsi-Korhonen L, et al. Grapefruit juice markedly increases the plasma concentrations and antiplatelet effects of ticagrelor in healthy subjects. Br J Clin Pharmacol. 2013;75(6):1488–1496. doi: 10.1111/bcp.12026
   PubMed Web of Science ®Google Scholar
• Won CS, Oberlies NH, Paine MF. Mechanisms underlying food–drug interactions: inhibition of intestinal metabolism and transport. Pharmacol Ther. 2012;136(2):186–201. doi: 10.1016/j.pharmthera.2012.08.001
   PubMed Web of Science ®Google Scholar
• Yasui N, Kondo T, Furukori H, et al. Effects of repeated ingestion of grapefruit juice on the single and multiple oral-dose pharmacokinetics and pharmacodynamics of alprazolam. Psychopharmacol (Berl). 2000;150(2):185–190. doi: 10.1007/s002130000438
   PubMed Web of Science ®Google Scholar
• Nahid NA, Johnson JA. CYP2D6 pharmacogenetics and phenoconversion in personalized medicine. Expert Opin Drug Metab Toxicol. 2022;18(11):769–785. doi: 10.1080/17425255.2022.2160317
   PubMed Web of Science ®Google Scholar
• Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138(1):103–141. doi: 10.1016/j.pharmthera.2012.12.007
   PubMed Web of Science ®Google Scholar
• Vanakoski J, Mattila MJ, Seppälä T. Grapefruit juice does not enhance the effects of midazolam and triazolam in man. Eur J Clin Pharmacol. 1996;50(6):501–508. doi: 10.1007/s002280050148
   PubMed Web of Science ®Google Scholar
• Andersen V, Pedersen N, Larsen NE, et al. Intestinal first pass metabolism of midazolam in liver cirrhosis –effect of grapefruit juice. Br J Clin Pharmacol. 2002;54(2):120–124. doi: 10.1046/j.1365-2125.2002.01615.x
   PubMed Web of Science ®Google Scholar
• Tanaka S, Uchida S, Miyakawa S, et al. Comparison of inhibitory duration of grapefruit juice on organic anion-transporting polypeptide and cytochrome p450 3A4. Biol Pharm Bull. 2013;36(12):1936–1941. doi: 10.1248/bpb.b13-00538
   PubMed Web of Science ®Google Scholar
• Culm-Merdek KE, Von Moltke LL, Gan L, et al. Effect of extended exposure to grapefruit juice on cytochrome P450 3A activity in humans: comparison with ritonavir. Clin Pharmacol Ther. 2006;79(3):243–254. doi: 10.1016/j.clpt.2005.11.009
   PubMed Web of Science ®Google Scholar
• Lilja JJ, Kivistö KT, Backman JT, et al. Grapefruit juice substantially increases plasma concentrations of buspirone. Clinical Pharm Ther. 1998;64(6):655–660. doi: 10.1016/S0009-9236(98)90056-X
   PubMed Web of Science ®Google Scholar
• Daniel WA, Bromek E, Danek P, et al. The mechanisms of interactions of psychotropic drugs with liver and brain cytochrome P450 and their significance for drug effect and drug-drug interactions. Biochem Pharmacol. 2022;199:115006. doi: 10.1016/j.bcp.2022.115006
   PubMed Web of Science ®Google Scholar
• Fuhr U, Majer A, Keller A, et al. Lacking effect of grapefruit juice on theophylline pharmacokinetics. Lacking effect of grapefruit juice on theophylline pharmacokinetics. Int J Clin Pharmacol Ther. 1995;33(6):311–314.
   PubMed Web of Science ®Google Scholar
• Lane HY, Jann MW, Chang YC, et al. Repeated ingestion of grapefruit juice does not alter clozapine’s steady-state plasma levels, effectiveness, and tolerability. J Clin Psychiatry. 2001;62(10):812–817. doi: 10.4088/jcp.v62n1010
   PubMed Web of Science ®Google Scholar
• Lane HY, Chiu CC, Kazmi Y, et al. Lack of CYP3A4 inhibition by grapefruit juice and ketoconazole upon clozapine administration in vivo. Drug Metabol Drug Interact. 2001;18(3–4):263–278. doi: 10.1515/dmdi.2001.18.3-4.263
   PubMedGoogle Scholar
• Özdemir V, Kalow W, Posner P, et al. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite norclozapine steady-state concentration in patients with schizophrenia. J Clin Psychopharmacol. 2001;21(4):398–407. doi: 10.1097/00004714-200108000-00007
   PubMed Web of Science ®Google Scholar
• Buur-Rasmussen B, Brøsen K. Cytochrome P450 and therapeutic drug monitoring with respect to clozapine. Eur Neuropsychopharmacol. 1999;9(6):453–459. doi: 10.1016/s0924-977x(99)00033-4
   PubMed Web of Science ®Google Scholar
• Molden E. Therapeutic drug monitoring of clozapine in adults with schizophrenia: a review of challenges and strategies. Expert Opin Drug Metab Toxicol. 2021;17(10):1211–1221. doi: 10.1080/17425255.2021.1974400
   PubMed Web of Science ®Google Scholar
• Vandel S, Netillard C, Perault MC, et al. Plasma levels of clozapine and desmethylclozapine are unaffected by concomitant ingestion of grapefruit juice. E J Clin Pharmacol. 2000;56(4):347–348. doi: 10.1007/s002280000126
   PubMed Web of Science ®Google Scholar
• de Leon J, Schoretsanitis G, Smith RL, et al. An international adult guideline for making clozapine titration safer by using six Ancestry-Based Personalized Dosing Titrations, CRP, and clozapine levels. Pharmacopsychiatry. 2022;55(2):73–86. doi: 10.1055/a-1625-6388
   PubMedGoogle Scholar
• DeSilva KE, Le Flore DB, Marston BJ, et al. Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine. AIDS. 2001;15(10):1281–1285. doi: 10.1097/00002030-200107060-00010
   PubMed Web of Science ®Google Scholar
• Stahl SM. Mechanism of action of trazodone: a multifunctional drug. CNS Spectr. 2009;14(10):536–546. doi: 10.1017/s1092852900024020
   PubMed Web of Science ®Google Scholar
• Dresser GK, Kim RB, Bailey DG. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides. Clin Pharmacol Ther. 2005;77(3):170–177. doi: 10.1016/j.clpt.2004.10.005
   PubMed Web of Science ®Google Scholar
• Andrade C. Fruit juice, organic anion transporting polypeptides, and drug interactions in psychiatry. J Clin Psychiatry. 2014;75(11):e1323–5. doi: 10.4088/JCP.14f09572
   PubMed Web of Science ®Google Scholar
• Mitsunaga Y, Takanaga H, Matsuo H, et al. Effect of bioflavonoids on vincristine transport across blood-brain barrier. Eur J Pharmacol. 2000;395(3):193–201. doi: 10.1016/s0014-2999(00)00180-1
   PubMed Web of Science ®Google Scholar
• de Leon J. The effects of antiepileptic inducers in neuropsychopharmacology, a neglected issue. Part II: pharmacological issues and further understanding. Rev Psiquiatr Salud Ment. 2015;8(3):167–188. doi: 10.1016/j.rpsm.2014.10.005
   PubMed Web of Science ®Google Scholar
• Parker RB, Yates CR, Soberman JE, et al. Effects of grapefruit juice on intestinal P-glycoprotein: evaluation using digoxin in humans. Pharmacotherapy. 2003;23(8):979–987. doi: 10.1592/phco.23.8.979.32881
   PubMed Web of Science ®Google Scholar
• Siwek M, Wojtasik-Bakalarz K, Krupa AJ, et al. Brexpiprazole—pharmacologic properties and use in schizophrenia and mood disorders. Brain Sci. 2023;13(3):397. doi: 10.3390/brainsci13030397
   PubMed Web of Science ®Google Scholar
• Siwek M, Krupa AJ, Wasik A. Lurasidone – pharmacodynamic and pharmacokinetic properties, clinical potential and interaction risk. Farmakoter Psychiatr Neurol. 2020;36(2):117–134. doi: 10.33450/10.33450/fpn.2020.06.002
   Google Scholar
• Siwek M, Chrobak AA, Gorostowicz A, et al. Cariprazine augmentation of clozapine in schizophrenia — a retrospective chart review. Cariprazine augmentation of clozapine in schizophrenia-a retrospective chart review. Front Pharmacol. 2024;14:1321112. doi: 10.3389/fphar.2023.1321112
   PubMed Web of Science ®Google Scholar
• Bazire S. Psychotropic drug directory 2020/21: the professionals’ pocket handbook and aide memoire. Salisbury: Lloyd-Reinhold Publications Ltd; 2020.
   Google Scholar
• Akamine Y, Yasui-Furukori N, Ieiri I, et al. Psychotropic drug-drug interactions involving P-glycoprotein. CNS Drugs. 2012;26(11):959–973. doi: 10.1007/s40263-012-0008-z
   PubMed Web of Science ®Google Scholar
• Spina E, Pisani F, de Leon J. Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics. Pharmacol Res. 2016;106:72–86. doi: 10.1016/j.phrs.2016.02.014
   PubMed Web of Science ®Google Scholar
• Spina E, Hiemke C, de Leon J. Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics. Expert Opin Drug Metab Toxicol. 2016;12(4):407–422. doi: 10.1517/17425255.2016.1154043
   PubMed Web of Science ®Google Scholar
• Chorin E, Hochstadt A, Granot Y, et al. Grapefruit juice prolongs the QT interval of healthy volunteers and patients with long QT syndrome. Heart Rhythm. 2019;16(8):1141–1148. doi: 10.1016/j.hrthm.2019.04.039
   PubMed Web of Science ®Google Scholar
• Piccirillo G, Magrì D, Matera S, et al. Effects of pink grapefruit juice on QT variability in patients with dilated or hypertensive cardiomyopathy and in healthy subjects. Transl Res. 2008;151(5):267–272. doi: 10.1016/j.trsl.2008.03.002
   PubMed Web of Science ®Google Scholar
• Zitron E, Scholz E, Owen RW, et al. Qtc prolongation by grapefruit juice and its potential pharmacological basis: HERG channel blockade by flavonoids. Circulation. 2005;111(7):835–838. doi: 10.1161/01.CIR.0000155617.54749.09
   PubMed Web of Science ®Google Scholar
• Tisdale JE, Chung MK, Campbell KB, et al. Drug-induced arrhythmias: a scientific statement from the American heart association. Circulation. 2020;42(15):e214–e233. doi: 10.1161/CIR.0000000000000905
   Google Scholar
• Degner D, Grohmann R, Kropp S, et al. Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry. 2004;37(Suppl 1):S39–45. doi: 10.1055/s-2004-815509
   PubMedGoogle Scholar
• Takemura M, Inoue K, Tamai I, et al. Magnitude of fruit juice-drug interactions due to osmolality-dependent fluid secretion: differences among Apple, Orange, and Grapefruit Juices. Biol Pharm Bull. 2024;47(1):72–78. doi: 10.1248/bpb.b23-00490
   PubMed Web of Science ®Google Scholar
• Ikegawa T, Ushigome F, Koyabu N, et al. Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. Cancer Lett. 2000;160(1):21–28. doi: 10.1016/s0304-3835(00)00549-8
   PubMed Web of Science ®Google Scholar
• Kim H, Yoon YJ, Shon JH, et al. Inhibitory effects of fruit juices on CYP3A activity. Drug Metab Dispos. 2006;34(4):521–523. doi: 10.1124/dmd.105.007930.
   PubMed Web of Science ®Google Scholar
• Backman JT, Mäenpää J, Belle DJ, et al. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation. Clin Pharmacol Ther. 2000;67(4):382–390. doi: 10.1067/mcp.2000.105756
   PubMed Web of Science ®Google Scholar
• Grenier J, Fradette C, Morelli G, et al. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther. 2006;79(3):255–262. doi: 10.1016/j.clpt.2005.11.010
   PubMed Web of Science ®Google Scholar
• Saito M, Hirata-Koizumi M, Matsumoto M, et al. Undesirable effects of citrus juice on the pharmacokinetics of drugs: focus on recent studies. Drug Saf. 2005;28(8):677–694. doi: 10.2165/00002018-200528080-00003
   PubMed Web of Science ®Google Scholar
• Ahmed T, Sajid M, Singh T, et al. Influence of grape juice and orange juice on the pharmacokinetics and pharmacodynamics of diltiazem in healthy human male subjects. Int J Clin Pharmacol Ther. 2008;46(10):511–518. doi: 10.5414/cpp46511
   PubMed Web of Science ®Google Scholar
• Farkas D, Greenblatt DJ. Influence of fruit juices on drug disposition: discrepancies between in vitro and clinical studies. Expert Opin Drug Metab Toxicol. 2008;4(4):381–393. doi: 10.1517/17425255.4.4.381
   PubMed Web of Science ®Google Scholar
• Farkas D, Oleson LE, Zhao Y, et al. Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: comparison with grapefruit juice. J Clin Pharmacol. 2007;47(3):286–294. doi: 10.1177/0091270006298359
   PubMed Web of Science ®Google Scholar
• Mansoor K, Bardees R, Alkhawaja B, et al. Impact of pomegranate juice on the pharmacokinetics of CYP3A4- and CYP2C9-mediated drugs metabolism: a preclinical and clinical review. Molecules. 2023;28(5):2117. doi: 10.3390/molecules28052117
   PubMed Web of Science ®Google Scholar
• Greenblatt DJ, Von Moltke LL, Perloff ES, et al. Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. Clin Pharmacol Ther. 2006;79(1):125–133. doi: 10.1016/j.clpt.2005.09.014
   PubMed Web of Science ®Google Scholar
• Oliveira-Freitas VL, Costa TD, Manfro RC, et al. Influence of purple grape juice in cyclosporine bioavailability. J Ren Nutr. 2010;20:309–313. doi: 10.1053/j.jrn.2010.01.007
   PubMed Web of Science ®Google Scholar
• Shalaby AS, Eid HH, El-Shiekh RA, et al. Taming food–drug interaction risk: potential inhibitory effects of citrus juices on cytochrome liver enzymes can safeguard the liver from overdose paracetamol-induced hepatotoxicity. ACS Omega. 2023;8(29):26444–26457. doi: 10.1021/acsomega.3c03100
   PubMed Web of Science ®Google Scholar
• Woroń J, Chrobak AA, Ślęzak D, et al. Unprescribed and unnoticed: retrospective chart review of adverse events of interactions between antidepressants and over-the-counter drugs. Front Pharmacol. 2022;13:965432. doi: 10.3389/fphar.2022.965432
   PubMed Web of Science ®Google Scholar
• Damsa C, Bumb A, Bianchi-Demicheli F, et al. “Dopamine-dependent” side effects of selective serotonin reuptake inhibitors: a clinical review. J Clin Psychiatry. 2004;65(8):1064–1068. doi: 10.4088/jcp.v65n0806
   PubMed Web of Science ®Google Scholar
• Collados V, Hallal H, Andrade RJ. Sertraline hepatotoxicity: report of a case and review of the literature. Dig Dis Sci. 2010;55(6):1806–1807. doi: 10.1007/s10620-010-1192-7
   PubMed Web of Science ®Google Scholar
• Collados Arroyo V, Plaza Aniorte J, Hallal H, et al. Hepatotoxicidad asociada a sertralina [Sertraline-induced hepatotoxicity]. Farm Hosp. 2008;32(1):60–61. doi: 10.1016/s1130-6343(08)72814-9
   PubMedGoogle Scholar
• Almansour MI, Jarrar YB, Jarrar BM. In vivo investigation on the chronic hepatotoxicity induced by sertraline. Environ Toxicol Pharmacol. 2018;61:107–115. doi: 10.1016/j.etap.2018.05.021
   PubMed Web of Science ®Google Scholar